I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 18 studies | 20% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 10 studies | 25% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 8 studies | 21% ± 4% | |
| retinal ganglion cell | 6 studies | 43% ± 26% | |
| epithelial cell | 6 studies | 26% ± 7% | |
| endothelial cell | 4 studies | 23% ± 3% | |
| glutamatergic neuron | 4 studies | 39% ± 20% | |
| type II pneumocyte | 4 studies | 26% ± 14% | |
| GABAergic neuron | 4 studies | 27% ± 10% | |
| mature NK T cell | 3 studies | 19% ± 4% | |
| amacrine cell | 3 studies | 21% ± 2% | |
| ciliated cell | 3 studies | 18% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| dendritic cell | 3 studies | 21% ± 3% | |
| basal cell | 3 studies | 24% ± 4% | |
| goblet cell | 3 studies | 21% ± 2% | |
| neuron | 3 studies | 25% ± 5% |
